Drug intelligence / Profile preview

NT-020

Development stage
Unknown
Lead developer
Natura Therapeutics
Modality
Small Molecules
Administration
Oral
01

Overview

NT-020 is a proprietary nutraceutical formulation developed by the University of South Florida's Center of Excellence for Aging and Brain Repair. It is a combination of natural ingredients, including blueberry extract (Vaccinium angustifolium), green tea extract (Camellia sinensis), L-carnosine, and vitamin D3. The compound is designed to enhance the proliferation of endogenous neural stem cells and provide neuroprotection by reducing oxidative stress and neuroinflammation. Mechanistically, NT-020 has been shown to activate the Nrf-2 and Wnt signaling pathways and decrease microglial activation. Clinical studies have evaluated its efficacy in improving cognitive performance, specifically processing speed and spatial memory, in healthy older adults.

Brand names
NutraStem
Other names
NT020NT-020NT 020
02

Targets

VDR (Vitamin D receptor)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on NT-020.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NT-020.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call